Effects of 2% Lidocaine viscous on systolic blood pressure response to orotracheal intubation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

TCTR

Registry ID

TCTR20180122003

Enrollment

Registered

2018-01-22

Start date

2018-01-22

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ptatient ASA I&#44

Interventions

Patient ASA I&#44

II under going elective surgery under GA with endotracheal tube age >= 18 years ,Patient ASA I&#44

II under going elective surgery under GA with endotracheal tube age >= 18 years

Experimental Drug,Experimental No treatment

Intervention group who recieved 2% Lidocaine viscous,Control group who recieved plai viscous

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Elective case ASA I,Ii Age >= 18 year

Exclusion criteria

Exclusion criteria: BW > 40 kg Aminoamide lidocaine allergy Oral ulcer Hypertension Hyperthyroid Arrhythmia Cardiac surgery Pregnancy Breast feeding Difficult airway Patients who recieve amiodarone, beta blocker, cimetidine, mexiletine, phenytoin Endotracheal intubation time > 30 sec or Endotracheal intubation more than 1 attempt

Design outcomes

Primary

Measure	Time frame
Effects of 2% Lidocaine viscous on systolic blood pressure response to orotracheal intubation Suddenly after ET tube marker pass vocal cord then every 1 minute until 15 minute NIBP	—

Secondary

Measure	Time frame
Heart rate Suddenly after ET tube marker pass vocal cord then every 1 minute until 15 minute NIBP,HR	—

Countries

Thailand

Contacts

Public ContactKittawan Sahananthrayuth

Khonkaen hospital

Kittawan-p@hotmail.com089-4221103

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026